Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of the gut microbiome on extra-intestinal autoimmune diseases
Eiji Miyauchi, Chikako Shimokawa, Alex Steimle, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 1, pp. 9-23
Closed Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 237
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 111
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 110
Gut microbiota and hypertension: association, mechanisms and treatment
Zhihua Yang, Qingchun Wang, Yangxi Liu, et al.
Clinical and Experimental Hypertension (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 81
Fecal microbiota transplantation: Emerging applications in autoimmune diseases
Ruixue Yang, Zhenzhen Chen, Jun Cai
Journal of Autoimmunity (2023) Vol. 141, pp. 103038-103038
Open Access | Times Cited: 47
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
Takato Kusakabe, Woan-Yu Lin, Jin‐Gyu Cheong, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1879-1889
Open Access | Times Cited: 43
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Emerging role of gut microbiota in autoimmune diseases
Xinyi Wang, Wei Yuan, Chunjuan Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility
Mathis Wolter, Erica T. Grant, Marie Boudaud, et al.
Molecular Systems Biology (2024) Vol. 20, Iss. 6, pp. 596-625
Open Access | Times Cited: 21
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases
Guoao Ding, Xuezhi Yang, Ying Li, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 19
Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives
Clelia Altieri, Barbara Speranza, Maria Rosaria Corbo, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 942-942
Open Access | Times Cited: 39
Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics
Sharlize Pedroza Matute, Sasitaran Iyavoo
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 39
Estrogen deficiency induces bone loss through the gut microbiota
Zhiyuan Guan, Zheng Xuanqi, Junxiong Zhu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106930-106930
Open Access | Times Cited: 34
Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
Yinghua Ma, David R. Sannino, Jennifer R. Linden, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 9
Open Access | Times Cited: 33
T helper 17 (Th17) cell responses to the gut microbiota in human diseases
Chao‐Yue Sun, Na Yang, Zuo-Liang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114483-114483
Open Access | Times Cited: 27
Genome-edited foods
Aytug Tuncel, Changtian Pan, Thorben Sprink, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 11, pp. 799-816
Open Access | Times Cited: 26
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 12
The multiple benefits of bioactive polysaccharides: from the gut to overall health
Renzhi Huang, Jia Zhang, Xinxin Xu, et al.
Trends in Food Science & Technology (2024) Vol. 152, pp. 104677-104677
Closed Access | Times Cited: 12
Impaired immune tolerance mediated by reduced Tfr cells in rheumatoid arthritis linked to gut microbiota dysbiosis and altered metabolites
Ruihe Wu, Dongming Wang, Liyun Cheng, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 11
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice
Shijie Cao, Erica Budina, Michal M. Raczy, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 5, pp. 611-627
Open Access | Times Cited: 11
Gut microbial factors predict disease severity in a mouse model of multiple sclerosis
Alex Steimle, Mareike Neumann, Erica T. Grant, et al.
Nature Microbiology (2024) Vol. 9, Iss. 9, pp. 2244-2261
Open Access | Times Cited: 11
Microbial Mechanisms of Rheumatoid Arthritis Pathogenesis
Brenda Seymour, Brendan Allen, Kristine A. Kuhn
Current Rheumatology Reports (2024) Vol. 26, Iss. 4, pp. 124-132
Closed Access | Times Cited: 10
The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever
Gregg J. Silverman, Doua F. Azzouz, Nicolas Gisch, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 3, pp. 143-157
Closed Access | Times Cited: 10
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top